Practice Guideline Briefs

Management of Postterm Pregnancy

Am Fam Physician. 2004 Nov 1;70(9):1808.

The Committee on Practice Bulletins—Obstetrics of the American College of Obstetricians and Gynecologists has released a new guideline entitled, “Management of Postterm Pregnancy.” The guideline appears in the September 2004 issue of Obstetrics and Gynecology and is available online at http://www.greenjournal.org/cgi/reprint/104/3/639.

Postterm pregnancy, by definition, refers to a pregnancy that has extended to or beyond 42 weeks of gestation. Accurate pregnancy dating is critical to the diagnosis. The term “postdate” is poorly defined and should be avoided. Although some cases of postterm pregnancy likely result from an inability to accurately define the estimated date of delivery, many cases result from a true prolongation of gestation. The reported frequency of postterm pregnancy is approximately 7 percent.

When postterm pregnancy truly exists, the cause usually is unknown. Primiparity and prior postterm pregnancy are the most common identifiable risk factors for prolongation of pregnancy. Rarely, postterm pregnancy may be associated with placental sulfatase deficiency or fetal anencephaly.

Postterm pregnancy is associated with significant risks to the infant. The perinatal mortality rate at more than 42 weeks of gestation is twice that at term and increases sixfold and higher at 43 weeks of gestation and beyond. Uteroplacental insufficiency, meconium aspiration, and intrauterine infection contribute to the increased rate of perinatal mortality. Postterm pregnancy also is an independent risk factor for low umbilical artery pH levels at delivery and low five-minute Apgar scores. For these reasons, the trend has been toward delivery by 41 completed weeks of gestation.

Although postterm infants are larger than term infants and have a higher incidence of fetal macrosomia, no evidence supports inducing labor as a preventive measure in such cases, according to the guideline. Complications associated with fetal macrosomia include prolonged labor, cephalopelvic disproportion, and shoulder dystocia with resultant risks of orthopedic or neurologic injury.

Approximately 20 percent of postterm infants have dysmaturity syndrome, which refers to infants with characteristics resembling chronic intrauterine growth restriction from uteroplacental insufficiency. These pregnancies are at increased risk for umbilical cord compression from oligohydramnios, meconium aspiration, and short-term neonatal complications, and have an increased incidence of nonreassuring fetal testing. Infants born postterm also are at increased risk of death within the first year of life, although some of these infant deaths clearly result from peripartum complications (such as meconium aspiration syndrome).

There are significant risks to the pregnant woman as well, including an increase in labor dystocia, an increase in severe perineal injury related to macrosomia, and a doubling in the rate of cesarean delivery. Cesarean delivery is associated with higher risks of complications, such as endometritis, hemorrhage, and thromboembolic disease. Finally, postterm pregnancy can be a source of substantial anxiety for the pregnant woman.

Summary of Recommendations

The following recommendations are based on good and consistent scientific evidence (Level A):

• Women with postterm gestations who have unfavorable cervices can undergo labor induction or be managed expectantly.

• Prostaglandin can be used in postterm pregnancies to promote cervical ripening and induce labor.

• Delivery should be effected if there is evidence of fetal compromise or oligohydramnios.

The following recommendations are based primarily on consensus and expert opinion (Level C):

• Despite a lack of evidence that monitoring improves perinatal outcome, it is reasonable to initiate antenatal surveillance of postterm pregnancies between 41 weeks (287 days; estimated delivery date + 7 days) and 42 weeks (294 days; estimated delivery date + 14 days) of gestation because of evidence that perinatal morbidity and mortality increase as gestational age advances.

• Many physicians use twice-weekly testing with some evaluation of amniotic fluid volume beginning at 41 weeks of gestation. A nonstress test and amniotic fluid volume assessment (a modified biophysical profile pBPP]) should be adequate.

• Many authorities recommend prompt delivery in a postterm patient with a favorable cervix and no other complications.

Summary of Recommendations

View Table

Summary of Recommendations

The following recommendations are based on good and consistent scientific evidence (Level A):

• Women with postterm gestations who have unfavorable cervices can undergo labor induction or be managed expectantly.

• Prostaglandin can be used in postterm pregnancies to promote cervical ripening and induce labor.

• Delivery should be effected if there is evidence of fetal compromise or oligohydramnios.

The following recommendations are based primarily on consensus and expert opinion (Level C):

• Despite a lack of evidence that monitoring improves perinatal outcome, it is reasonable to initiate antenatal surveillance of postterm pregnancies between 41 weeks (287 days; estimated delivery date + 7 days) and 42 weeks (294 days; estimated delivery date + 14 days) of gestation because of evidence that perinatal morbidity and mortality increase as gestational age advances.

• Many physicians use twice-weekly testing with some evaluation of amniotic fluid volume beginning at 41 weeks of gestation. A nonstress test and amniotic fluid volume assessment (a modified biophysical profile pBPP]) should be adequate.

• Many authorities recommend prompt delivery in a postterm patient with a favorable cervix and no other complications.


Copyright © 2004 by the American Academy of Family Physicians.
This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. Contact afpserv@aafp.org for copyright questions and/or permission requests.

Want to use this article elsewhere? Get Permissions


Article Tools

  • Print page
  • Share this page
  • AFP CME Quiz

Information From Industry

Navigate this Article